Analysis: Alcon uncertainty masking Novartis drug promise - Reuters UK

Reuters UK

Analysis: Alcon uncertainty masking Novartis drug promise Reuters UK Data from its gout drug Ilaris and its meningitis vaccine pipeline also due later this year further underline the diversity of the group's treatments. ... and more »

EULAR: Models Look at Costs of Gout Treatment - MedPage Today

EULAR: Models Look at Costs of Gout Treatment MedPage Today "Allopurinol has been the standard pharmaceutical treatment for gout for over 40 years," Meltzer told MedPage Today at her poster presentation. ... Febuxostat Appears to Outperform Allopurinol in Percentage of Gout Patients ...DG News EULAR: Gout Not 'Cured' Until Crystals DropMedPage Today all 5 news articles »

EULAR: Experimental Compound Helps Gout Patients, Lowers Uric Acid - MedPage Today

EULAR: Experimental Compound Helps Gout Patients, Lowers Uric Acid MedPage Today RDEA594 is not yet available as a treatment for gout except through participation in clinical trials. ... EULAR: Canakinumab Prevents Flares in Gout PatientsMedPage Today EULAR: Febuxostat Bests Allopurinol in GoutMedPage Today all 8 news articles »

EULAR 2010 Gout Highlights From Jonathan Kay, MD - Medscape

EULAR 2010 Gout Highlights From Jonathan Kay, MD Medscape The authors concluded that, in gout patients initiating allopurinol therapy, treatment with canakinumab led to a statistically significant reduction in ...